Literature DB >> 19141446

Reverse genetics-generated elastase-dependent swine influenza viruses are attenuated in pigs.

Aleksandar Masic1, Lorne A Babiuk1, Yan Zhou1.   

Abstract

Influenza A virus causes significant morbidity in swine, resulting in a substantial economic burden. Swine influenza virus (SIV) infection also poses important human public health concerns. It has been shown that conversion of the haemagglutinin (HA) cleavage site from a trypsin-sensitive motif to an elastase-sensitive motif resulted in attenuated viruses in mouse models. However, application of this attenuation approach in a natural host has not been achieved yet. Here, we report that using reverse genetics, we generated two mutant SIVs derived from strain A/SW/SK/18789/02 (H1N1). Mutant A/SW/SK-R345V carries a mutation from arginine to valine at aa 345 of HA. Similarly, mutant A/SW/SK-R345A encodes alanine instead of arginine at aa 345 of HA. Our data showed that both mutants are solely dependent on neutrophil elastase cleavage in tissue culture. These tissue culture-grown mutant SIVs showed similar growth properties in terms of plaque size and growth kinetics to the wild-type virus. In addition, SIV mutants were able to maintain their genetic information after multiple passaging on MDCK cells. Furthermore, mutant SIVs were highly attenuated in pigs. Thus, these mutants may have the potential to serve as live attenuated vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141446     DOI: 10.1099/vir.0.005447-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

Review 1.  From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses.

Authors:  Julijan Kabiljo; Johannes Laengle; Michael Bergmann
Journal:  Cell Death Discov       Date:  2020-06-11

2.  Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.

Authors:  Lindomar Pena; Amy L Vincent; Jianqiang Ye; Janice R Ciacci-Zanella; Matthew Angel; Alessio Lorusso; Philip C Gauger; Bruce H Janke; Crystal L Loving; Daniel R Perez
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

3.  5'-Triphosphate-short interfering RNA: potent inhibition of influenza A virus infection by gene silencing and RIG-I activation.

Authors:  Li Lin; Qiang Liu; Nathalie Berube; Susan Detmer; Yan Zhou
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

4.  Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs.

Authors:  Aleksandar Masic; Jayaum S Booth; George K Mutwiri; Lorne A Babiuk; Yan Zhou
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

5.  A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.

Authors:  Xingui Tian; Shelby Landreth; Yao Lu; Kannupriya Pandey; Yan Zhou
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

6.  An eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs.

Authors:  Aleksandar Masic; Hyun-Mi Pyo; Shawn Babiuk; Yan Zhou
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

7.  Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge.

Authors:  Jinhwa Lee; Yonghai Li; Yuhao Li; A Giselle Cino-Ozuna; Michael Duff; Yuekun Lang; Jingjiao Ma; Sunyoung Sunwoo; Juergen A Richt; Wenjun Ma
Journal:  Vaccine       Date:  2021-03-11       Impact factor: 3.641

Review 8.  Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective.

Authors:  Guan Yang; Jürgen A Richt; John P Driver
Journal:  Int J Mol Sci       Date:  2017-12-27       Impact factor: 5.923

Review 9.  Optimal Use of Vaccines for Control of Influenza A Virus in Swine.

Authors:  Matthew R Sandbulte; Anna R Spickler; Pamela K Zaabel; James A Roth
Journal:  Vaccines (Basel)       Date:  2015-01-30

10.  Networks of Host Factors that Interact with NS1 Protein of Influenza A Virus.

Authors:  Sathya N Thulasi Raman; Yan Zhou
Journal:  Front Microbiol       Date:  2016-05-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.